Corporate Banner
Satellite Banner
Technology Networks Header
Friday, April 18, 2014
Technology Networks
Register | Sign in
Home Page>News

  News Archive

Vermillion Reports Fourth Quarter and Full Year 2013 Results
Saturday, March 08, 2014
Company will next pursue a national price for its OVA1 test in 2014.

Cellmid Announces That British Journal of Pharmacology Features Midkine
Saturday, March 08, 2014
BJP features midkine in a special edition with 16 new publications.

3-D Changes in DNA May Lead to a Genetic Form of Lou Gehrig’s Disease
Friday, March 07, 2014
NIH-funded scientists reveal how a genetic code variation results in devastating brain diseases.

NexImmune’s AIM™ Technology Enables Novel Adoptive Immunotherapy Approach for Cancer Treatment
Friday, March 07, 2014
New scientific publication by NexImmune co-founder Dr. Jonathan Schneck.

Curie-Cancer and DNA Therapeutics Partner in the Fight Against Cancers
Thursday, March 06, 2014
Their clinical and translational research program has developed Dbait molecules now in Phase I clinical trial in patients with advanced melanoma.

OGT Announces Acquisition of Cytocell Ltd
Thursday, March 06, 2014
Company expands leadership in genomic medicine.

Genticel Launches its Phase II Trial in Women Infected with High-Risk HPV
Thursday, March 06, 2014
The appointment of Dr. Sophie Olivier as chief medical officer completes the Genticel team to run the Phase II trial across Europe.

Insight Genetics and Vanderbilt-Ingram Cancer Center Partner
Wednesday, March 05, 2014
Research collaboration includes exclusive licensing agreement to commercialize a new genetic test that will improve treatment selection for breast cancer patients with poor prognosis.

Novogen Appoints New Board Members and Strategic Advisor
Wednesday, March 05, 2014
Appointments to support transition to clinical development and growing international presence.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 8677
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to